Found 115 matching trials
Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine PHASE3 This is an observer-blinded Phase 3 study to evaluate the safety and immuno...
Show More Location
Cleveland Clinic Abu Dhabi
Learn More & Join Trial
A FIRST IN HUMAN TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF SARS-CoV-2 UQSC2 VACCINE IN HEALTHY ADULTS. PHASE1 This will be a single centre, Phase 1, First-In-Human , Randomized, Active-...
Show More Location
QPharm Pty.Ltd. (Nucleus Network Brisbane)
Learn More & Join Trial
Phase 3 Pivotal Trial of NanoFlu™ in Older Adults PHASE3 A Phase 3, randomized, observer-blinded, active-controlled trial to evaluat...
Show More Learn More & Join Trial
Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali PHASE1 Background:
Researchers are trying to develop a vaccine that will safely r...
Show More Location
Malaria Research Training Center
Learn More & Join Trial
Glycemic and Insulinemic Index Determination of Two Products: Fructilight® and A Fruit Fructo-Oligosaccharides in Sweet Matrix NA The aim of the study is to determine glycemic and insulinemic index of 2 sw...
Show More Learn More & Join Trial
A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant PHASE1 This is a study in which healthy adult volunteers will be given either an e...
Show More Location
Centre National de Recherche et de Formatation sur le Paludisme (CNRFP)/Unite de Recherche Clinique de Banfora (URC-B)
Learn More & Join Trial
Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania. PHASE1 A phase Ib age de-escalation and dose escalation open label clinical trial ...
Show More Location
Ifakara Health Institute Clinical Trial Facility
Learn More & Join Trial
Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines PHASE3 This study is a large-scale investigation (Phase 3) into a new booster shot...
Show More Location
Alfa Medical Research
Learn More & Join Trial
Safety and Efficacy of R0.6C Vaccine PHASE1 This is a first-in-human phase I, open-label, single-site, dose escalation ...
Show More Location
Radboud university medical center
Learn More & Join Trial
Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant PHASE1 Assessing the safety, immunogenicity and ex-vivo efficacy of two transmissi...
Show More Status
Active Not Recruiting
Location
Institut des Sciences et Techniques (INSTech)
Learn More & Join Trial